Sponsor:
University of North Carolina, Chapel Hill
Code:
NCT06312683
Conditions
Pouchitis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Rifaximin 550 MG Oral Tablet [XIFAXAN]
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-13. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2025-07-11.